Stocks · Health care · Pharmaceutical Preparations

OnKure Therapeutics, Inc.

OKUR Clue Score34
United States Fiscal year ends December CIK 0001637715 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ashley Hall
28 Aug 2023
Chief Development Officer
Sold after exercise
15,625
$6.28
$98.06K

What was left out

Form 4 filings counted 133
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 13,328,761
Sales filed before the plan box existed 1
History held since 12 Apr 2021